Reverberi C - Search Results

1

Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment: a mono-institutional experience.

Valeriani M, Marinelli L, Macrini S, Reverberi C, Aschelter AM, De Sanctis V, Marchetti P, Tronnolone L, Osti MF. Valeriani M, et al. Among authors: reverberi c. Radiat Oncol. 2019 Nov 14;14(1):205. doi: 10.1186/s13014-019-1414-x. Radiat Oncol. 2019. PMID: 31727093 Free PMC article.

2

Mono- and Bi-weekly Hypofractionated Radiation Therapy for the Treatment of Epithelial Skin Cancer in Very Elderly Patients.

Valeriani M, Nicosia L, Agolli L, Reverberi C, Galvagno E, DE Sanctis V, Minniti G, Carlesimo M, Osti MF. Valeriani M, et al. Among authors: reverberi c. Anticancer Res. 2017 Feb;37(2):825-830. doi: 10.21873/anticanres.11384. Anticancer Res. 2017. PMID: 28179337

3

Moderate Hypofractionation in Patients with Low-risk Prostate Cancer: Long-term Outcomes.

Valeriani M, Bonfili P, Reverberi C, Marinelli L, Ferella L, Minniti G, DE Sanctis V, Osti MF, Bonome P, Tronnolone L, Varrassi E, Gravina GL, Franzese P, Tombolini V, DI Staso M. Valeriani M, et al. Among authors: reverberi c. Anticancer Res. 2018 Mar;38(3):1671-1676. doi: 10.21873/anticanres.12400. Anticancer Res. 2018. PMID: 29491101

4

30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic disease.

Osti MF, Agolli L, Valeriani M, Reverberi C, Bracci S, Marinelli L, De Sanctis V, Cortesi E, Martelli M, De Dominicis C, Minniti G, Nicosia L. Osti MF, et al. Among authors: reverberi c. Lung Cancer. 2018 Aug;122:165-170. doi: 10.1016/j.lungcan.2018.06.018. Epub 2018 Jun 13. Lung Cancer. 2018. PMID: 30032826

5

Inoperable early-stage primary and early recurrent non-small cell lung cancer: outcomes of a mono-institutional experience using a moderate hypofractionated schedule.

Valeriani M, Marinelli L, Reverberi C, De Sanctis V, Mollo D, Nicosia L, Osti MF. Valeriani M, et al. Among authors: reverberi c. Radiol Med. 2019 Jan;124(1):58-64. doi: 10.1007/s11547-018-0934-z. Epub 2018 Sep 3. Radiol Med. 2019. PMID: 30178173

6

Single nucleotide polymorphism of <italic>GSTP1</italic> and pathological complete response in locally advanced rectal cancer patients treated with neoadjuvant concomitant radiochemotherapy.

Nicosia L, Gentile G, Reverberi C, Minniti G, Valeriani M, de Sanctis V, Marinelli L, Cipolla F, de Luca O, Simmaco M, Osti MF. Nicosia L, et al. Among authors: reverberi c. Radiat Oncol J. 2018 Sep;36(3):218-226. doi: 10.3857/roj.2018.00094. Epub 2018 Sep 30. Radiat Oncol J. 2018. PMID: 30309213 Free PMC article.

7

Salvage radiotherapy with simultaneous integrated boost in non small-cell lung cancer patients with mediastinal relapse after surgery: a pilot study.

Nicosia L, Agolli L, Reverberi C, De Sanctis V, Marinelli L, Minniti G, Di Muzio J, Valeriani M, Osti MF. Nicosia L, et al. Among authors: reverberi c. Radiat Oncol. 2018 Oct 23;13(1):207. doi: 10.1186/s13014-018-1155-2. Radiat Oncol. 2018. PMID: 30352607 Free PMC article.

8

Orbital Radiotherapy Plus Concomitant Steroids in Moderate-to-Severe Graves' Ophthalmopathy: Good Results After Long-Term Follow-Up.

Nicosia L, Reverberi C, Agolli L, Marinelli L, De Sanctis V, Minniti G, Valeriani M, Osti MF. Nicosia L, et al. Among authors: reverberi c. Int J Endocrinol Metab. 2019 Jan 27;17(1):e84427. doi: 10.5812/ijem.84427. eCollection 2019 Jan. Int J Endocrinol Metab. 2019. PMID: 30881470 Free PMC article.

9

Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity.

Minniti G, Anzellini D, Reverberi C, Cappellini GCA, Marchetti L, Bianciardi F, Bozzao A, Osti M, Gentile PC, Esposito V. Minniti G, et al. Among authors: reverberi c. J Immunother Cancer. 2019 Apr 11;7(1):102. doi: 10.1186/s40425-019-0588-y. J Immunother Cancer. 2019. PMID: 30975225 Free PMC article.

10

Locally advanced inoperable primary or recurrent non-small cell lung cancer treated with 4-week hypofractionated radiation therapy (3 Gy/fraction).

Valeriani M, Marinelli L, Nicosia L, Reverberi C, De Sanctis V, Mollo D, Osti MF. Valeriani M, et al. Among authors: reverberi c. Radiol Med. 2019 Dec;124(12):1324-1332. doi: 10.1007/s11547-019-01064-2. Epub 2019 Jul 17. Radiol Med. 2019. PMID: 31317381

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters